Treatment with psychedelics is psychotherapy: beyond reductionism

Area of Science:

• Psychiatry
• Neuroscience
• Psychopharmacology

Background:

• Psychedelic substances are emerging as a promising treatment for psychiatric disorders.
• Historically, psychedelic-assisted psychotherapy has been viewed as a synergistic process.
• Recent studies challenge this, suggesting therapeutic effects stem solely from the substance, with psychotherapy as mere support.

Purpose of the Study:

• To contrast the traditional view of psychedelic-assisted psychotherapy with a substance-centric model.
• To argue against a reductionistic, dualistic approach to psychedelic treatments in psychiatry.
• To discuss implications for research and regulation of psychedelic compounds.

Main Methods:

• This is a conceptual review and personal view, not an empirical study.
• It contrasts two prevailing conceptualizations of psychedelic-assisted therapy.
• It analyzes the historical and current perspectives on the role of psychotherapy.

Main Results:

• The paper argues that viewing psychedelic treatment as purely biological with minimal psychotherapy is an outdated dualistic perspective.
• It posits that the psychotherapy component is crucial for both safety and efficacy.
• The authors advocate for a holistic understanding of psychedelic-assisted psychotherapy.

Conclusions:

• Characterizing psychedelic treatment as a biological intervention with safety-focused psychological support is reductionistic.
• The psychotherapy component is integral to the therapeutic mechanism of action.
• This perspective has significant implications for the future study and regulation of psychedelic therapies.